News
Cancer immunotherapy represents a transformative approach in oncology, especially for treating cancers thought to be incurable. However, a significant ...
A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...
A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published ...
Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...
A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...
Liquid Web, a leader in dedicated servers, WordPress, VPS, GPU, and cloud hosting solutions for small to medium-sized businesses (SMBs), today announced the release ...
While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...
Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Best-in-Class PTRS, today announced compelling results from a new study demonstrating the ability of the Cellworks Platform ...
Generally, the standard treatment for solid tumors is surgery. However, a recent study from New York City-based Memorial Sloan Kettering Cancer Center found immunotherapy can effectively treat these ...
LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs.
Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in ...
The new trial expanded on a smaller study from Cercek that used the immunotherapy drug dostarlimab as the first treatment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results